Cargando…
Classic and Variants APLs, as Viewed from a Therapy Response
Most acute promyelocytic leukemia (APL) are caused by PML-RARA, a translocation-driven fusion oncoprotein discovered three decades ago. Over the years, several other types of rare X-RARA fusions have been described, while recently, oncogenic fusion proteins involving other retinoic acid receptors (R...
Autores principales: | Geoffroy, Marie-Claude, de Thé, Hugues |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226009/ https://www.ncbi.nlm.nih.gov/pubmed/32295268 http://dx.doi.org/10.3390/cancers12040967 |
Ejemplares similares
-
Comment on Geoffroy, M.-C.; de Thé, H. Classic and Variants APLs, as Viewed from a Therapy Response. Cancers 2020, 12, 967
por: Su, Zhan, et al.
Publicado: (2021) -
Uncoupling RARA transcriptional activation and degradation clarifies the bases for APL response to therapies
por: Ablain, Julien, et al.
Publicado: (2013) -
APL Congress
por: Gjerløv, Per, et al.
Publicado: (1973) -
APL : a short course
por: Pakin, Sandra
Publicado: (1973) -
APL2 in depth
por: Thomson, Norman D, et al.
Publicado: (1995)